O GoConqr está de visual novo! Conte para nós o que você achou.

Quiz

pathoanatomy mcq-s 251-350

timi Lamikanra 100 perguntas 5,0 (2 avaliações)

Fazer o quiz

Perguntas do quiz (100)

  1. 1select the epithelial ovarian tumours
    1. Agranulosa cell tumor
    2. Bthecoma
    3. Cbrenner's tumor
    4. Dandroblastoma
  2. 2252: which of the following are epithelial ovarian tumors
    1. Athecoma
    2. Bserous granuloma
    3. Cdysgerminoma
    4. Dbrenner's tumor
  3. 3253: which of the following are sex-ord stromal ovarian tumors
    1. Agranulosa cell tumor
    2. Bthecoma
    3. Cdysgerminoma
    4. Dandroblastoma
  4. 4254: which of the following ovarian tumors are benign
    1. Apapillary cystadenoma
    2. Bpapillary cystadenocarcinoma
    3. Cdysgerminoma
    4. Dthecoma
  5. 5255: which of the following ovarian tumors are malignant
    1. Aserous cystadenoma
    2. Bendodermal yolk sac tumor
    3. Cthecoma
    4. Dmucinous cystadenocarcinoma
  6. 6256: in fibro-cystic breast disease we find the following
    1. Asolitary nodule
    2. Bmultiple nodules
    3. Ccyst
    4. Dpapillary proliferations
  7. 7257: in fibroadenoma of the breast we find
    1. Amultiple nodules
    2. Bcysts
    3. Csolitary nodules
    4. Dproliferated mammary ducts and stroma
  8. 8258: benign prostate hyperplaia is seen most commonly in
    1. Amedian lobe
    2. BSubscapular prostate tissuee
    3. Clateral lobes
    4. Dperiurethreal prostate tissue
  9. 9259: prostate carcinoma is usualy seen in
    1. Alateral lobe
    2. Bpossterior lobe
    3. Cperiuretheral prostatic tissue
    4. Dsubcapsular prostate tissue
  10. 10260: which two markers are valuable for the diagnosis of prostate cancer
    1. APSA
    2. BHER2
    3. CPAP
    4. Destrogen receptors

Informações

Descrição
Quiz sobre pathoanatomy mcq-s 251-350, criado por timi Lamikanra em 17-01-2018.
Idioma
English
Visualizações
538
Avaliação
5,0 de 5 · 2 avaliações
Avalie este quiz
Avalie este quiz

Fale Conosco

Sobre o que é sua mensagem?

O que você acha do novo visual?

Você gostou?